サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1442910

イムノアッセイ - 世界市場の考察、競合情勢、市場予測（2030年）

Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
イムノアッセイ - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のイムノアッセイの市場規模は、2024年～2030年の予測期間にCAGRで7.53%の大幅な成長が見込まれています。イムノアッセイの需要は主に、がんなどの慢性疾患や糖尿病などの生活習慣病の有病率の増加によって押し上げられています。乳がんや前立腺がんなどのさまざまな腫瘍性疾患の増加は、市場のプラス成長に影響を与える主な要因です。さらに、疾病の早期診断に関する人々の意識の高まりも、2024年～2030年の予測期間におけるイムノアッセイ市場の全体的な成長に寄与しています。

イムノアッセイの市場力学

International Diabetes Federation（IDF）（2021）によると、2021年に全世界で20～79歳の成人約5億3,700万人が糖尿病を患っています。また、同じ資料によると、2030年までに世界全体で約6億4,300万人が糖尿病に罹患するとされています。インスリンやCペプチドなど、糖尿病に関連するさまざまなバイオマーカーは、イムノアッセイで正確に検出することができます。したがって、糖尿病の有病率の増加はイムノアッセイの需要を増加させ、市場成長に寄与します。

世界保健機関（WHO）（2022）によると、2020年に世界で報告された乳がん症例は約226万件、肺がん症例は221万件、大腸がん症例は193万件でした。したがって、肺がん、乳がん、前立腺がんなどの成人のがん症例が増加していることに加え、医師がこれらの疾患のバイオマーカー検査を毎年受けるよう推奨していることが、イムノアッセイ市場を加速させる見通しです。

さらに、HIV、肝炎などの感染症が増加していることも、イムノアッセイ市場の主な促進要因の1つです。世界保健機関（WHO）（2022）によると、2022年に全世界で約3億5,400万人がB型肝炎またはC型肝炎に感染していると推定されています。したがって、感染症患者の増加は、診断の需要をさらに増加させ、市場成長に寄与します。

しかし、イムノアッセイの検査キットや器具に関連する技術的問題や、高いコスト、これらの複雑な検査の実施に求められる熟練した専門家の不足などが、イムノアッセイ市場の成長を抑制する可能性のある市場障壁となっています。

イムノアッセイ市場のセグメント分析

イムノアッセイ市場の製品セグメントでは、試薬・キットカテゴリが2023年に大きな収益シェアを獲得する見込みです。これは、世界中で慢性疾患や感染症が増加しているため、イムノアッセイキットや試薬の需要や消費が高いことや、イムノアッセイ検査の実施件数の増加に起因しています。さらに、高い感度や強い特異性など、イムノアッセイキットが提供するさまざまな利点も、このセグメントの成長に寄与する要因の1つです。

さらに、キットや試薬は検査のたびに必要とされるため、検査プロセスに不可欠な要素となっています。

さらに、このセグメントに対する需要の高まりに伴い、数多くの新製品が市場に投入されています。2021年2月、Agilent Technologiesは、ヒト血清または血漿中のSARS-CoV-2に対する免疫グロブリンG（IgG）抗体の検出に使用されるAgilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay（ELISA）キットを発売しました。

したがって、上記の要因により、試薬・キットカテゴリは大きな成長を記録すると予測され、それによって予測期間にイムノアッセイ市場全体の成長を促進します。

北米がイムノアッセイ市場全体を独占すると予測されます。

全地域の中で、北米が2023年のイムノアッセイ市場で最大のシェアを占めると推定されます。これは、同地域に不健康な生活習慣が存在し、糖尿病や甲状腺疾患などのさまざまな生活習慣病の患者が多いことによるものと考えられます。さらに、疾患の診断に関する消費者の高い意識や、政府の支援、製品の開発と発売における優位性なども、同地域の市場成長に影響を与える要因です。

当レポートでは、世界のイムノアッセイ市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 イムノアッセイ市場レポートのイントロダクション

第2章 イムノアッセイ市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 イムノアッセイ市場の主な要因の分析

  • イムノアッセイ市場の促進要因
  • イムノアッセイ市場の抑制要因と課題
  • イムノアッセイ市場の機会

第5章 イムノアッセイ市場のポーターのファイブフォース分析

第6章 イムノアッセイ市場のレイアウト

  • 製品別
    • 試薬・キット
    • 器具
  • 技術別
    • ラジオイムノアッセイ
    • 酵素イムノアッセイ
    • 蛍光イムノアッセイ
    • 化学発光イムノアッセイ
    • その他
  • 用途別
    • 感染症検査
    • 心臓
    • 腫瘍
    • 内分泌
    • 自己免疫疾患
  • 標本別
    • 血液
    • 尿
    • 唾液
  • エンドユーザー別
    • 病院・診療所
    • 診断検査室
    • 製薬・バイオテクノロジー産業
  • 地域
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 イムノアッセイ市場の企業と製品のプロファイル

  • Beckman Coulter, Inc.
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Autobio
  • PHC Corporation
  • Trivitron Healthcare
  • Werfen
  • Danaher Corporation
  • Sysmex Corporation
  • ALPCO
  • Quidel Corporation
  • ZECEN Biotech Co. Ltd.
  • Awareness Technology
  • Diatron
  • Macscura Biotechnology Co.
  • Guangzhou Jinde Biotech Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Medcaptain Medical Technology Co., Ltd.

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Immunoassay Market in Global (2021-2030)
  • Table 3: Immunoassay Market in Global by Product (2021-2030)
  • Table 4: Immunoassay Market in Global by Technology (2021-2030)
  • Table 5: Immunoassay Market in Global by Application (2021-2030)
  • Table 6: Immunoassay Market in Global by Sample (2021-2030)
  • Table 7: Immunoassay Market in Global by End-User (2021-2030)
  • Table 8: Immunoassay Market in Global by Geography (2021-2030)
  • Table 9: Immunoassay Market in North America (2021-2030)
  • Table 10: Immunoassay Market in North America by Country (2021-2030)
  • Table 11: Immunoassay Market in the United States (2021-2030)
  • Table 12: Immunoassay Market in Canada (2021-2030)
  • Table 13: Immunoassay Market in Mexico (2021-2030)
  • Table 14: Immunoassay Market in Europe (2021-2030)
  • Table 15: Immunoassay Market in Europe by Country (2021-2030)
  • Table 16: Immunoassay Market in France (2021-2030)
  • Table 17: Immunoassay Market in Germany (2021-2030)
  • Table 18: Immunoassay Market in the United Kingdom (2021-2030)
  • Table 19: Immunoassay Market in Italy (2021-2030)
  • Table 20: Immunoassay Market in Spain (2021-2030)
  • Table 21: Immunoassay Market in the Rest of Europe (2021-2030)
  • Table 22: Immunoassay Market in Asia-Pacific (2021-2030)
  • Table 23: Immunoassay Market in Asia-Pacific by Country (2021-2030)
  • Table 24: Immunoassay Market in China (2021-2030)
  • Table 25: Immunoassay Market in Japan (2021-2030)
  • Table 26: Immunoassay Market in India (2021-2030)
  • Table 27: Immunoassay Market in Australia (2021-2030)
  • Table 28: Immunoassay Market in South Korea (2021-2030)
  • Table 29: Immunoassay Market in Rest of Asia-Pacific (2021-2030)
  • Table 30: Immunoassay Market in the Rest of the World (2021-2030)
  • Table 31: Immunoassay Market in RoW by Region (2021-2030)
  • Table 32: Immunoassay Market in the Middle East (2021-2030)
  • Table 33: Immunoassay Market in Africa (2021-2030)
  • Table 34: Immunoassay Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Immunoassay Market in Global (2021-2030)
  • Figure 3: Immunoassay Market in Global by Product (2021-2030)
  • Figure 4: Immunoassay Market in Global by Technology (2021-2030)
  • Figure 5: Immunoassay Market in Global by Application (2021-2030)
  • Figure 6: Immunoassay Market in Global by Sample (2021-2030)
  • Figure 7: Immunoassay Market in Global by End-User (2021-2030)
  • Figure 8: Immunoassay Market in Global by Geography (2021-2030)
  • Figure 9: Immunoassay Market in North America (2021-2030)
  • Figure 10: Immunoassay Market in North America by Country (2021-2030)
  • Figure 11: Immunoassay Market in the United States (2021-2030)
  • Figure 12: Immunoassay Market in Canada (2021-2030)
  • Figure 13: Immunoassay Market in Mexico (2021-2030)
  • Figure 14: Immunoassay Market in Europe (2021-2030)
  • Figure 15: Immunoassay Market in Europe by Country (2021-2030)
  • Figure 16: Immunoassay Market in France (2021-2030)
  • Figure 17: Immunoassay Market in Germany (2021-2030)
  • Figure 18: Immunoassay Market in the United Kingdom (2021-2030)
  • Figure 19: Immunoassay Market in Italy (2021-2030)
  • Figure 20: Immunoassay Market in Spain (2021-2030)
  • Figure 21: Immunoassay Market in the Rest of Europe (2021-2030)
  • Figure 22: Immunoassay Market in Asia-Pacific (2021-2030)
  • Figure 23: Immunoassay Market in Asia-Pacific by Country (2021-2030)
  • Figure 24: Immunoassay Market in China (2021-2030)
  • Figure 25: Immunoassay Market in Japan (2021-2030)
  • Figure 26: Immunoassay Market in India (2021-2030)
  • Figure 27: Immunoassay Market in Australia (2021-2030)
  • Figure 28: Immunoassay Market in South Korea (2021-2030)
  • Figure 29: Immunoassay Market in Rest of Asia-Pacific (2021-2030)
  • Figure 30: Immunoassay Market in the Rest of the World (2021-2030)
  • Figure 31: Immunoassay Market in RoW by Region (2021-2030)
  • Figure 32: Immunoassay Market in the Middle East (2021-2030)
  • Figure 33: Immunoassay Market in Africa (2021-2030)
  • Figure 34: Immunoassay Market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0696

Immunoassay Market By Product (Reagents & Kits And Instruments), Technology (Radioimmunoassay, Enzyme-Linked Immunoassay, Chemiluminescence Immunoassay, Fluoroimmunoassay, And Others), Sample (Blood, Urine, Saliva, And Others), Application (Oncology, Cardiology, Infectious Disease Testing, Endocrinology, Autoimmune Disorders, And Others), End-User (Hospitals & Clinics, Diagnostic Labs, Pharmaceuticals & Biotech Industries, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases such as cancer, lifestyle diseases such as diabetes mellitus, and others, and the growing prevalence of infectious diseases such as hepatitis, hiv, and others

The global Immunoassay market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period from 2024 to 2030. The demand for immunoassay is primarily being boosted by the increasing prevalence of chronic disorders such as cancers, and lifestyle disorders such as diabetes mellitus, among others. The increase in various oncological disorders such as breast cancer and prostate cancer is a key factor influencing the positive growth of the market. Further, the rising awareness among people regarding early disease diagnosis is also contributing to the overall growth of the immunoassay market during the forecast period from 2024-2030.

Immunoassay Market Dynamics:

As per the International Diabetes Federation (IDF) 2021, worldwide around 537 million adults aged between 20 and 79 years had diabetes in the year 2021. Also, according to the same source around 643 million people will be suffering from diabetes by 2030, globally. The various biomarkers associated with diabetes mellitus such as insulin and C-peptide can be detected accurately with immunoassay. Thus, the rising prevalence of diabetes will increase the demand for immunoassay, thereby contributing to its market growth.

As per the World Health Organization (WHO) 2022, there were around 2.26 million cases of breast cancer, 2.21 million cases of lung cancer, and 1.93 million cases of colon and rectal cancer, reported in the year 2020 globally. Therefore, the rising cases of cancers such as lung, breast, and prostate cancer amongst the adult population as well as the recommendation of annual tests for biomarkers of these diseases by doctors is going to accelerate the market for immunoassay.

Further, the rising cases of infectious disorders such as HIV, hepatitis, and others is another key driver for the immunoassay market, as immunoassays are widely used for the diagnosis of infectious disorders. According to the World Health Organization (WHO) 2022, it was estimated that in 2022, around 354 million people were living with Hepatitis B or C infections, globally. Therefore, the increasing cases of infectious diseases will further increase the demand for diagnosis, thus contributing to market growth.

However, technical issues associated with the immunoassay test kits and instruments, high costs, along with the lack of skilled professionals required to perform these complicated tests are some of the market barriers that may restrict the growth of the immunoassay market.

Immunoassay Market Segment Analysis:

Immunoassay Market by Product (Reagents & Kits and Instruments), Technology (Radioimmunoassay, Enzyme-Linked Immunoassay, Chemiluminescence Immunoassay, Fluoroimmunoassay, and Others), Sample (Blood, Urine, Saliva, and Others), Application (Oncology, Cardiology, Infectious Disease Testing, Endocrinology, Autoimmune Disorders, and Others), End-User (Hospitals & Clinics, Diagnostic Labs, Pharmaceuticals & Biotech Industries, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the Immunoassay market, the reagents & kits category is expected to amass a significant revenue share in the year 2023. This can be attributed to the high demand and consumption of immunoassay kits and reagents and the increasing number of immunoassay tests performed, due to the increasing number of chronic and infectious disorders around the globe. Additionally, various advantages provided by immunoassay kits such as high sensitivity and strong specificity are also some of the factors contributing to the growth of the segment.

Further, the kits and reagents are required for every test making them an integral part of the testing process.

Furthermore, with the growing demand for this segment, numerous new products are being launched in the market. In February 2021, Agilent Technologies launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, which is used for the detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

Therefore, owing to the above-mentioned factors, the reagents & kits category is expected to register significant growth, thereby driving the growth of the overall Immunoassay market during the forecast period.

North America is expected to dominate the overall Immunoassay Market:

Among all the regions, North America is estimated to account for the largest share of the Immunoassay market in the year 2023. This can be attributed to the presence of unhealthy lifestyles in the region contributing to a large patient pool suffering from various lifestyle disorders such as diabetes mellitus and thyroid diseases. Additionally, high consumer awareness regarding disease diagnosis, government support, and a dominant market in terms of product development and launches are among other factors influencing the growth of the market in the region.

One of the prominent factors supporting the growth of the North America immunoassay market is the extensive use of immunoassay in the detection of tumor markers indicating cancer development. For instance, according to National Cancer Institute 2020, it was estimated that around 1,806,590 cancer cases were diagnosed in the year 2020 in the United States. Additionally, as per the same source prostate, lung, and colorectal cancer accounted for 43% of the cancer cases in men, and breast, lung, and colorectal making up to 50% of cancer cases in women.

Further, according to the data provided by The Government of Canada 2021, cancer is one of the leading causes of death in Canada. In 2021, around 229,200 Canadians were diagnosed with cancer and 84,600 people died from cancer in Canada. This indicates the huge need for early detection of the diseases, therefore leading to the growth of immunoassay market in the region.

Moreover, the rise in chronic and cardiovascular diseases such as coronary artery diseases, and stroke among the US population is another driver of the immunoassay market. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, around 18.2 million people aged 20 or above had coronary artery disease in the United States. Also, as per the same source around 805,000 people face heart attacks every year in the United States. This indicates the huge need for immunoassay for the detection of cardiac markers assisting in the identification of cardiovascular disorders and therefore leading to market growth of immunoassay.

Therefore, the factors mentioned above, and the increasing awareness of people regarding early disease diagnosis in the region are some of the important factors which are thereby responsible for driving the market in North America during the forecast period.

Immunoassay Market Key Players:

Some of the key market players operating in the immunoassay market include Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, ALPCO, Autobio, PHC Corporation, Trivitorn Healthcare, Werfen, Danaher Corporation, Sysmex Corporation, Awareness Technology Inc, ZECEN Biotech Co., Quidel Corporation, among others.

Recent Developmental Activities in the Immunoassay Market:

  • In August 2023, Fapon Biotech launched its latest chemiluminescence immunoassay analyzer. The Shine i8000/9000 consists of innovative features and has an ultra-high throughput of 900 tests per hour.
  • In November 2022, Gethin Biotech introduced the new MAGICAL 6000 chemiluminescence immunoassay Analyzer at MEDICA.
  • In April 2021, Snibe, Diagnostic received CE marking for Maglumi HIV Ab/Ag Combi CLIA kit which detects HIV-1 and HIV-2 antibodies and the HIV-1 p24 antigen.

Key Takeaways from the Immunoassay Market Report Study

  • Market size analysis for current immunoassay market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/and technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global immunoassay market.
  • Various opportunities available for the other competitors in the immunoassay market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current immunoassay market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for immunoassay market growth in the coming future?

Target Audience who can be benefited from this Immunoassay Market Report Study

  • Immunoassay product providers
  • Research organizations and consulting companies
  • Immunoassay-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Immunoassay
  • Various end-users who want to know more about the immunoassay market and the latest technological developments in the Immunoassay market

Frequently Asked Questions for the Immunoassay Market:

1. What is meant by Immunoassay?

Immunoassays are bioanalytical methods that usually employ the specificity of antigen-antibody reactions to detect the target molecules in the samples. These are highly specific and sensitive and the reagents used are antibodies and purified antigens, which contribute to their great specificity.

2. What is the market for global Immunoassay?

The global Immunoassay market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Immunoassay market?

The immunoassay market is slated to witness prosperity owing to factors such as the growing prevalence of chronic diseases such as cancers, thyroid diseases, lifestyle disorders such as diabetes mellitus, and others. Additionally, there is a large patient pool suffering from various cardiovascular and autoimmune disorders globally. Further, the rising awareness of health, the growing focus on improving accuracy, affordability, portability, and usability of immunoassay for end-users are expected to result in the appreciable revenue growth of the immunoassay market during the forecast period (2024-2030).

4. Who are the key players operating in the global immunoassay market?

Some of the key market players operating in the Immunoassay market include Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, ALPCO, Autobio, PHC Corporation, Trivitorn Healthcare, Werfen, Danaher Corporation, Sysmex Corporation, Awareness Technology Inc., ZECEN Biotech Co., Quidel Corporation, among others.

5. Which region has the highest share in the global immunoassay market?

North America is expected to dominate the overall Immunoassay Market during the forecast period from 2024 to 2030. Due to the presence of a large patient pool associated with various diseases such as diabetes mellitus, and cardiovascular diseases this can be further attributed to the poor lifestyle of people. Further, the region has a very potent market for product development and launches, a high level of consumer knowledge regarding new market launches, support from the government, and the presence of local and significant market players.

Table of Contents

1. Immunoassay Market Report Introduction

2. Immunoassay Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Immunoassay Market Key Factors Analysis

  • 4.1. Immunoassay Market Drivers
    • 4.1.1. Increasing prevalence of chronic disorders such as cancers, lifestyle disorders such as diabetes mellitus, and others
    • 4.1.2. Increasing cases of infectious disorders such as HIV, hepatitis, and others
    • 4.1.3. Growing awareness among people regarding early disease diagnosis
  • 4.2. Immunoassay Market Restraints and Challenges
    • 4.2.1. Technical issues associated with immunoassay kits and instruments
    • 4.2.2. High costs and lack of skilled healthcare experts
  • 4.3. Immunoassay Market Opportunities
    • 4.3.1. Technological advancements such as enhanced product accuracy
    • 4.3.2. Increase in affordability and availability of portable and easy-to-use diagnostic equipment

5. Immunoassay Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Immunoassay Market Layout

  • 6.1. By Product
    • 6.1.1. Reagents & Kits
    • 6.1.2. Instruments
  • 6.2. By Technology
    • 6.2.1. Radioimmunoassay
    • 6.2.2. Enzyme Linked Immunoassay
    • 6.2.3. Fluoroimmunoassay
    • 6.2.4. Chemiluminescence Immunoassay
    • 6.2.5. Others
  • 6.3. By Application
    • 6.3.1. Infectious Disease Testing
    • 6.3.2. Cardiology
    • 6.3.3. Oncology
    • 6.3.4. Endocrinology
    • 6.3.5. Autoimmune Disorders
    • 6.3.6. Others
  • 6.4. By Sample
    • 6.4.1. Blood
    • 6.4.2. Urine
    • 6.4.3. Saliva
  • 6.5. By End-User
    • 6.5.1. Hospitals & Clinics
    • 6.5.2. Diagnostic Labs
    • 6.5.3. Pharmaceutical & Biotech Industries
    • 6.5.4. Others
  • 6.6. By Geography
    • 6.6.1. North America
      • 6.6.1.1. United States Immunoassay Market Size in USD million (2021-2030)
      • 6.6.1.2. Canada Immunoassay Market Size in USD million (2021-2030)
      • 6.6.1.3. Mexico Immunoassay Market Size in USD million (2021-2030)
    • 6.6.2. Europe
      • 6.6.2.1. France Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.2. Germany Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.3. United Kingdom Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.4. Italy Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.5. Spain Immunoassay Market Size in USD million (2021-2030)
      • 6.6.2.6. Rest of Europe Immunoassay Market Size in USD million (2021-2030)
    • 6.6.3. Asia-Pacific
      • 6.6.3.1. China Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.2. Japan Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.3. India Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.4. Australia Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.5. South Korea Immunoassay Market Size in USD million (2021-2030)
      • 6.6.3.6. Rest of Asia-Pacific Immunoassay Market Size in USD million (2021-2030)
    • 6.6.4. Rest of the World (RoW)
      • 6.6.4.1. Middle East Immunoassay Market Size in USD million (2021-2030)
      • 6.6.4.2. Africa Immunoassay Market Size in USD million (2021-2030)
      • 6.6.4.3. South America Immunoassay Market Size in USD million (2021-2030)

7. Immunoassay Market Company and Product Profiles

  • 7.1. Beckman Coulter, Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Siemens Healthcare GmbH
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. F. Hoffmann-La Roche Ltd.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Abbott Laboratories
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Thermo Fisher Scientific, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Autobio
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. PHC Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Trivitron Healthcare
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Werfen
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Danaher Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Sysmex Corporation
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. ALPCO
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Quidel Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. ZECEN Biotech Co. Ltd.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Awareness Technology
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Diatron
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Macscura Biotechnology Co.
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Guangzhou Jinde Biotech Co., Ltd.
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Medcaptain Medical Technology Co., Ltd.
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us